Bio-Rad Laboratories, Inc. (BIO) vs Charles River Laboratories International, Inc. (CRL)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Charles River Laboratories International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs CRL

growth of $100 · dividends reinvested · last 26y
BIO +2717.0%CRL +992.9%BIO compounded faster
02k4k6kStart $10020052010201520202025$2,817$1,093
BIO CRL

BIO vs CRL: by the numbers

  • CRL is the larger company ($11.31B vs $8.85B market cap).
  • BIO is profitable (6.52% net margin) while CRL runs a net loss (-4.59%).
  • CRL grew revenue faster over the past five years (5.77% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOCRL
P/E ratio54.53N/A
Forward P/E36.6121.65
P/S ratio3.452.92
P/B ratio1.304.00
EV / EBITDA22.3817.76
FCF yield4.00%3.32%

Profitability

MetricBIOCRL
Gross margin51.87%31.86%
Operating margin9.25%11.77%
Net margin6.52%-4.59%
ROE2.46%-6.28%
ROIC2.04%8.36%

Growth (annualized)

MetricBIOCRL
Revenue CAGR (5Y)0.29%5.77%
EPS CAGR (5Y)-26.27%-40.99%
FCF CAGR (5Y)-7.57%6.43%
Total return CAGR (5Y)-14.06%-9.66%

Frequently asked

Which has grown faster, BIO or CRL?
Over the past five years, CRL grew revenue faster — BIO at a 0.29% CAGR versus CRL at 5.77%.
Is BIO or CRL more profitable?
BIO runs the higher net margin — BIO at 6.52% versus CRL at -4.59%.
How have BIO and CRL total returns compared?
Over the past 10 years, BIO delivered 8.64% and CRL delivered 10.64% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.